Novavax Hosts HM King Carl XVI Gustaf and HM Queen Silvia of Sweden During Royal Visit to Uppsala County
GAITHERSBURG, Md., Sept. 24, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, hosted HM King Carl XVI Gustaf and HM Queen Silvia for a visit to Novavax AB, the company's Uppsala, Sweden manufacturing affiliate on Thursday, September 23. The visit included a discussion of NVX-CoV2373, Novavax' recombinant nanoparticle protein-based COVID-19 vaccine candidate, and the company's role in combatting the global pandemic.
"We applaud the royal family for their exceptional leadership in supporting vaccination efforts to end the pandemic both in Sweden and globally," said Magnus Sävenhed, Managing Director, Novavax AB. "Novavax AB was delighted to share an overview of our progress and operations as we continue to grow our presence in Uppsala and build a global vaccine arsenal in the fight against COVID-19."….
ir.novavax.com/...Sweden-During-Royal-Visit-to-Uppsala-County